3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Prostate Cancer -

Pomegranate juice promising for prostate cancer

Prostate CancerSep 27, 05

Pomegranate extract may prevent prostate cancer or slow its growth, if results of lab experiments conducted at the University of Wisconsin in Madison translate to real-world benefits.

Dr. Hasan Mukhtar and his colleagues note in the Proceedings of the National Academy of Sciences Early Edition that pomegranates are high in polyphenolic compounds, making its juice higher in antioxidant activity than red wine and green tea.

When they incubated prostate cancer cells with low concentrations of pomegranate extract, they observed a dose-related inhibition of cell growth.

In prostate cancer cells driven by male hormones (androgens) and expressing prostate specific antigen (PSA), treatment with pomegranate extract decreased androgen receptors and PSA expression.

When human prostate cancer cells were injected into mice, feeding the animals pomegranate extract delayed the appearance of tumors. Tumor growth was significantly inhibited and survival was prolonged.

As for whether pomegranate juice could be recommended to men with prostate cancer, Mukhtar told Reuters Health: “Based on the data we have it’s highly unlikely that it will produce any adverse effects and it is highly possible that it will produce useful effects.”

Moreover, he added, since his group has also shown that pomegranate extract inhibits skin cancer growth, it is possible that the juice would be of benefit in many types of cancer.

SOURCE: Proceedings of the National Academy of Sciences, Early Edition September 26, 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Pain drugs used in prostate gland removal linked to cancer outcome, Mayo Clinic-led study finds
  Study Shows Physicians Reluctant to Use Chemoprevention for Prostate Cancer
  Chemist Refines Technique to Treat Prostate Cancer with Light
  Men from deprived areas less likely to be treated for prostate cancer
  Obesity and weight gain near time of prostate cancer surgery doubles risk of recurrence
  U.S. Medicare panel to weigh prostate treatments
  LSUHSC researcher finds first inherited prostate cancer genetic mutation in African-American men
  New study links masturbation and prostate cancer
  Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds
  Low cholesterol may shrink risk for high-grade prostate cancer
  PMH clinicians map group at high risk for aggressive, ‘hidden’ prostate cancer
  “Watchful waiting” often works for prostate cancer

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site